
Kroger's corrected fiscal second-quarter filing presents a split operating picture. Adjusted diluted earnings per share rose 5% from the prior year, and the adjusted FIFO gross-margin rate excluding rent, depreciation, amortization, and fuel improved 13 basis points. Those comparisons are explicitly period-supported. Identical sales excluding fuel increased 0.2%, versus 3.4% a year earlier, and the company lowered its full-year range to 0.2% through 0.8% from 1.0% through 2.0%. The evidence therefore supports higher per-share earnings alongside slower sales, not a claim of broad operating momentum.
Management attributed a combined 265-basis-point sales drag to drug-pricing changes, a shift toward generic prescriptions, a Cyclospora outbreak affecting produce demand, and egg deflation. The source also reports increased traffic while grocery unit growth decelerated. Management said performance was better than Circana's Rest of Market measure, but the copied review notes that this comparison is not a fully independent, audited market-share series. That limit matters when interpreting the sales result.
Several operating levers helped frame the quarter. E-commerce sales grew 20%, retail media grew 24%, fuel gallons outpaced the wider market by about 520 basis points, and pharmacy operating profit benefited from branded-to-generic mix. At the same time, the operating, general, and administrative rate rose 33 basis points as wages, health costs, shrink, transportation, and sales deleverage weighed against productivity efforts. Full-year profit, adjusted earnings, and cash-flow ranges remained unchanged alongside lower sales expectations, placing more analytical weight on continued execution.
The next dated company checkpoint is the October 20 investor update. The useful questions are whether grocery units stabilize, digital profitability and retail media continue to contribute, and gross-margin progress can offset expense pressure. The corrected September 11 SEC exhibit controls the evidence; the superseded exhibit from earlier that day does not. The research boundary ends with the completed September 11 regular session, so later developments are outside this note.
Read the complete Kroger research note.
Market analysis, not personalized investment advice.

